Time-resolved perfusion imaging at the angiography suite preclinical comparison of a new flat-detector application to computed tomography perfusion

Investigative Radiology

Volumn 50, Issue 2, 2015, Pages 108-113

  Jürgens, Julian H W ^a   Schulz, Nadine ^a   Wybranski, Christian ^a   Seidensticker, Max ^a   Streit, Sebastian ^a   Brauner, Jan ^a   Wohlgemuth, Walter A ^b   Deuerling Zheng, Yu ^c   Ricke, Jens ^a   Dudeck, Oliver ^a,d  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c SIEMENS AG   (Germany)

^d Deutsche Akademie für Mikrotherapie International School of Image Guided Interventions   (Germany)

Author keywords

Angiography; CT perfusion; Flat detector CT perfusion; Flat panel detector; VX2 tumor

Indexed keywords

IOMEPROL;

ANGIOGRAPHY; ANGIOGRAPHY DEVICE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION COEFFICIENT; DIAGNOSTIC IMAGING EQUIPMENT; EXPERIMENTAL MODEL; FLAT PANEL DETECTOR; IMAGE PROCESSING; IMAGING SOFTWARE; LINEAR REGRESSION ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; TIME RESOLVED PERFUSION IMAGING; TUMOR MODEL; ALGORITHM; ANIMAL; COMPUTER ASSISTED DIAGNOSIS; COMPUTER PROGRAM; DEVICES; EXPERIMENTAL NEOPLASM; IMAGE QUALITY; PROCEDURES; RADIOGRAPHY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TUMOR CELL LINE; X RAY FILM;

ALGORITHMS; ANGIOGRAPHY; ANIMALS; CELL LINE, TUMOR; NEOPLASMS, EXPERIMENTAL; RABBITS; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOFTWARE; TOMOGRAPHY, X-RAY COMPUTED; X-RAY INTENSIFYING SCREENS;

EID: 84925961928     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0000000000000107     Document Type: Article

References (48)

1. Kalender WA, Kyriakou Y. Flat-detector computed tomography (FD-CT). Eur Radiol. 2007;17:2767-2779.
2. Struffert T, Richter G, Engelhorn T, et al. Visualisation of intracerebral haemorrhage with flat-detector CT compared to multislice CT: results in 44 cases. Eur Radiol. 2009;19:619-625.
3. Engelhorn T, Struffert T, Richter G, et al. Flat panel detector angiographic CT in the management of aneurysmal rupture during coil embolization. AJNR Am J Neuroradiol. 2008;29:1581-1584.
4. Plank C, Wolf F, Langenberger H, et al. Adrenal venous sampling using dyna-CT-a practical guide. Eur J Radiol. 2012;81:2304-2307.
5. Kulkarni C, Sreekumar KP, Prabhu NK, et al. Utility of C-arm CT in overcoming challenges in patients undergoing transarterial chemoembolization for hepatocellular carcinoma. Indian J Radiol Imaging. 2014;24:80-83.
6. Benndorf G, Strother CM, Claus B, et al. Angiographic CT in cerebrovascular stenting. AJNR Am J Neuroradiol. 2005;26:1813-1818.
7. Louie JD, Kothary N, Kuo WT, et al. Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. J Vasc Interv Radiol. 2009;20:606-613.
8. Fiorella D, Turk A, Chaudry I, et al. A prospective, multicenter pilot study investigating the utility of flat detector derived parenchymal blood volume maps to estimate cerebral blood volume in stroke patients. J Neurointerv Surg. 2014;6:451-456.
9. Struffert T, Deuerling-Zheng Y, Kloska S, et al. Cerebral blood volume imaging by flat detector computed tomography in comparison to conventional multislice perfusion CT. Eur Radiol. 2011;21:882-889.
10. Ahmed AS, Zellerhoff M, Strother CM, et al. C-arm CT measurement of cerebral blood volume: an experimental study in canines. AJNR Am J Neuroradiol. 2009;30:917-922.
11. Ganguly A, Fieselmann A, Marks M, et al. Cerebral CT perfusion using an interventional C-arm imaging system: cerebral blood flow measurements. AJNR Am J Neuroradiol. 2011;32:1525-1531.
12. Minami Y, Kudo M. Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma: ultrasonography, CT and MR imaging. Oncology. 2013;84(suppl 1):58-63.
13. Dudeck O, Zeile M, Wybranski C, et al. Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy. Eur Radiol. 2010;20:2699-2706.
14. Salem R, Lewandowski RJ, Atassi B, et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (Therasphere): safety, tumor response, and survival. J Vasc Interv Radiol. 2005;16:1627-1639.
15. Goh V, Halligan S, Daley F, et al. Colorectal tumor vascularity: quantitative assessment with multidetector CT-do tumor perfusion measurements reflect angiogenesis? Radiology. 2008;249:510-517.
16. Bellomi M, Petralia G, Sonzogni A, et al. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. Radiology. 2007;244:486-493.
17. Tacelli N, Santangelo T, Scherpereel A, et al. Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and anti-angiogenic chemotherapy. Eur Radiol. 2013;23:2127-2136.
18. Dong Y, Lei GW, Wang SW, et al. Diagnostic value of CT perfusion imaging for parotid neoplasms. Dentomaxillofac Radiol. 2014;43:20130237.
19. Razek AA, Tawfik AM, Elsorogy LG, et al. PerfusionCTof head and neck cancer. Eur J Radiol. 2014;83:537-544.
20. Arya S, Rane P, Deshmukh A. Oral cavity squamous cell carcinoma: role of pretreatment imaging and its influence on management. Clin Radiol. 2014;69:916-930.
21. Shope RE, Hurst EW. Infectious papillomatosis of rabbits: with a note on the histopathology. J Exp Med. 1933;58:607-624.
22. Royalty K, Manhart M, Pulfer K, et al. C-arm CT measurement of cerebral blood volume and cerebral blood flow using a novel high-speed acquisition and a single intravenous contrast injection. AJNR Am J Neuroradiol. 2013;34:2131-2138.
23. Yildirim IO, Baysal T, Celik MR. The evaluation of MDCT and quantitative first-pass perfusion in lung cancers. Eur Rev Med Pharmacol Sci. 2013;17:2390-2395.
24. Sauter AW, Winterstein S, Spira D, et al. Multifunctional profiling of non-small cell lung cancer using 18 F-FDG PET/CT and volume perfusion CT. J Nucl Med. 2012;53:521-529.
25. Xia X, Du R, Zhao L, et al. Expression of AEG-1 and microvessel density correlates with metastasis and prognosis oforal squamous cell carcinoma. Hum Pathol. 2014;45:858-865.
26. Morsbach F, Sah BR, Spring L, et al. Perfusion CT best predicts outcome after radioembolization of liver metastases: a comparison of radionuclide and CT imaging techniques. Eur Radiol. 2014;24:1455-1465.
27. Struffert T, Hauer M, Banckwitz R, et al. Effective dose to patient measurements in flat-detector and multislice computed tomography: a comparison of applications in neuroradiology. Eur Radiol. 2014;24:1257-1265.
28. Goh V, Ng QS, Miles K. Computed tomography perfusion imaging for therapeutic assessment: has it come of age as a biomarker in oncology? Invest Radiol. 2012;47:2-4.
29. Wang H, Farjam R, Feng M, et al. Arterial perfusion imaging-defined subvolume of intrahepatic cancer. Int J Radiat Oncol Biol Phys. 2014;89:167-174.
30. Weber MA, Thilmann C, Lichy MP, et al. Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibilityweighted contrast-enhanced perfusion MRI: initial results. Invest Radiol. 2004;39:277-287.
31. Carlomagno F, Chiariello M. Growth factor transduction pathways: paradigm of anti-neoplastic targeted therapy. J Mol Med (Berl). 2014;92:723-733.
32. Faivre S, Djelloul S, Raymond E. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. Semin Oncol. 2006;33:407-420.
33. Wiedmann MW, Caca K. Molecularly targeted therapy for gastrointestinal cancer. Curr Cancer Drug Targets. 2005;5:171-193.
34. Alvarez RH, Valero V, Hortobagyi GN. Emerging targeted therapies for breast cancer. J Clin Oncol. 2010;28:3366-3379.
35. Llovet JM, Ducreux M, Lencioni R, et al. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908-943.
36. Spira D, Neumeister H, Spira SM, et al. Assessment of tumor vascularity in lung cancer using volume perfusion CT (VPCT) with histopathologic comparison: a further step toward an individualized tumor characterization. J Comput Assist Tomogr. 2013;37:15-21.
37. Reiner CS, Roessle M, Thiesler T, et al. Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers. Invest Radiol. 2013;48:183-191.
38. Reiner CS, Goetti R, Eberli D, et al. CT perfusion of renal cell carcinoma: impact of volume coverage on quantitative analysis. Invest Radiol. 2012;47:33-40.
39. Hendlisz A, Van Den Eynde M, Peeters M, et al. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. J Clin Oncol. 2010;28:3687-3694.
40. Nicolay NH, Berry DP, Sharma RA. Liver metastases from colorectal cancer: radioembolization with systemic therapy. Nat Rev Clin Oncol. 2009;6:687-697.
41. Hilgard P, Muller S, Hamami M, et al. Selective internal radiotherapy (radioembolization) and radiation therapy for HCC-current status and perspectives [in German]. Z Gastroenterol. 2009;47:37-54.
42. Campbell AM, Bailey IH, Burton MA. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol. 2000;45:1023-1033.
43. Salem R, Lewandowski RJ, Mulcahy MF, et al. Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of longterm outcomes. Gastroenterology. 2010;138:52-64.
44. Seidensticker R, Denecke T, Kraus P, et al. Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases. Cardiovasc Intervent Radiol. 2012;35:1066-1073.
45. Ray CE Jr, Battaglia C, Libby AM, et al. Interventional radiologic treatment of hepatocellular carcinoma-a cost analysis from the payer perspective. J Vasc Interv Radiol. 2012;23:306-314.
46. Jakobs TF, Hoffmann RT, Poepperl G, et al. Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90) yttrium resin-microspheres. Eur Radiol. 2007;17:1320-1330.
47. Reiner CS, Morsbach F, Sah BR, et al. Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion. J Vasc Interv Radiol. 2014;25:747-759.
48. Morsbach F, Pfammatter T, Reiner CS, et al. Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases. Invest Radiol. 2013;48:787-794.